These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27480855)

  • 1. Characterization of CTX-M-140, a Variant of CTX-M-14 Extended-Spectrum β-Lactamase with Decreased Cephalosporin Hydrolytic Activity, from Cephalosporin-Resistant Proteus mirabilis.
    Tian GB; Jiang YQ; Huang YM; Qin Y; Feng LQ; Zhang XF; Li HY; Zhong LL; Zeng KJ; Patil S; Xing Y; Huang X
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6121-6. PubMed ID: 27480855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
    Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
    J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
    Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
    Rajivgandhi G; Maruthupandy M; Manoharan N
    Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional Spread of CTX-M-2-Producing Proteus mirabilis with the Identical Genetic Structure in Japan.
    Kato K; Matsumura Y; Yamamoto M; Nagao M; Takakura S; Ichiyama S
    Microb Drug Resist; 2017 Jul; 23(5):590-595. PubMed ID: 27834610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
    Tian GB; Huang YM; Fang ZL; Qing Y; Zhang XF; Huang X
    J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
    Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.
    Navon-Venezia S; Chmelnitsky I; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2008 Aug; 62(2):289-95. PubMed ID: 18487232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal location of the fosA3 and bla
    He D; Liu L; Guo B; Wu S; Chen X; Wang J; Zeng Z; Liu JH
    Int J Antimicrob Agents; 2017 Apr; 49(4):443-448. PubMed ID: 28238801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
    J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
    Woodford N; Ward ME; Kaufmann ME; Turton J; Fagan EJ; James D; Johnson AP; Pike R; Warner M; Cheasty T; Pearson A; Harry S; Leach JB; Loughrey A; Lowes JA; Warren RE; Livermore DM
    J Antimicrob Chemother; 2004 Oct; 54(4):735-43. PubMed ID: 15347638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.
    Timofte D; Maciuca IE; Williams NJ; Wattret A; Schmidt V
    Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.